JUN 28, 2017 12:01 PM PDT

Stem Cells Treat Asthma?

WRITTEN BY: Kara Marker
2 11 390

A new treatment for chronic asthma could help people who don’t respond to the standard corticosteroids, who don't have any other options. A new breed of stem cells appears to be the answer, cells capable of reversing the negative effects of asthma on lung tissue.

The new approach to treating chronic asthma is based on induced pluripotent stem cell-derived mesenchymal stem cells (MSCs) from Cynata Therapeutics, an Australian “clinical-stage stem cell and regenerative medicine company.”

What are induced pluripotent stem cells, and what makes them a promising component of a new asthma treatment? These types of stem cells can be directly acquired from adult stem cells and can differentiate (transform into) other types of cells, such as lung cells to recharge lung tissue damaged from chronic asthma.

From Monash University in Australia, researchers tested the therapeutic effect of MSCs - delivered intranasally - in a model of experimental asthma, examining their influence on three components of asthma: inflammation, airway remodeling, airway hyperresponsiveness (the classic symptom of asthma). How effective are MSCs at treating these components? Quite. MSCs reduced inflammation, reversed negative effects of airway remodeling, and returned lung tissue scarring and hyperresponsiveness back to its normal state.

"When we've tested other types of stem cells they haven't been able to fully reverse scarring and lung dysfunction associated with asthma - we've had to combine them with anti-scarring drugs to achieve that,” explained lead researcher Chrishan Samuel. “These cells were remarkable on their own as they were able to effectively reverse the scarring that contributes to lung dysfunction and difficulty in breathing.”

Turned into a new treatment option, MSCs could either provide a new chance for asthma patients not responding to standard corticosteroid therapy or a completely new treatment for people who simply want another choice. In the future, MSCs as an asthma treatment will be tested in comparison to and in combination with standard corticosteroid treatments.

The present study was published in the FASEB Journal.

Source: Monash University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 12, 2018
Clinical & Molecular DX
MAR 12, 2018
New Nanopore Sensor Detects Molecule in Osteoarthritis
A new sensory tool to detect and diagnose inflammatory diseases measures and analyzes molecules as they pass single-file through a hole on a microchip that
MAR 22, 2018
Health & Medicine
MAR 22, 2018
The FluMist Vaccine Will Be Back
While the numbers are starting to go down and it looks like this year's record-setting flu season is ending, the CDC and other health experts are still
APR 02, 2018
Immunology
APR 02, 2018
How does Johne's disease evade the immune system?
An infectious disease that afflicts cattle all over the world is particularly devastating because it can inhibit the animals’ immune systems. In a ne
MAY 04, 2018
Clinical & Molecular DX
MAY 04, 2018
New Blood Test Detects Peanut Allergy with 98% Specificity
A new blood test trumps traditional diagnostic methods for determining peanut allergy, the most common allergy for children. From the Medical Research Coun
MAY 31, 2018
Immunology
MAY 31, 2018
Immunosuppressant Drugs to Prevent Parkinson's Disease
Certain immune activity could be increasing a person’s risk of developing Parkinson’s disease (PD), but immunosuppressant drugs might solve the
JUN 12, 2018
Immunology
JUN 12, 2018
Auto-antibody Detection for Rheumatoid Arthritis Patients
No case of rheumatoid arthritis (RA), an autoimmune disease, is the same. Now, researchers want RA diagnostic approaches to match its pathological diversit
Loading Comments...